Fractional Inactivated Poliovirus Vaccine Booster and Rotavirus Study

NCT02847026 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1144

Enrollment

FED

Sponsor class

Conditions

Poliomyelitis

Interventions

BIOLOGICAL: IPV at 14 and 22 weeks of age, Rotarix
BIOLOGICAL: IPV at 14 and 22 weeks of age, RotaTeq
BIOLOGICAL: IPV at 14 and fIPV at 22 weeks, Rotarix
BIOLOGICAL: IPV at 14 and fIPV at 22 weeks, RotaTeq
BIOLOGICAL: IPV at 6 and fIPV at 22 weeks, Rotarix
BIOLOGICAL: IPV at 6 and fIPV at 22 weeks, RotaTeq
BIOLOGICAL: fIPV at 6-14-22 weeks of age, Rotarix
BIOLOGICAL: fIPV at 6-14-22 weeks of age, RotaTeq

Sponsor

Centers for Disease Control and Prevention

Collaborators

[object Object]